ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,104.27
1.11%
US Tech 100
17,243.80
1.57%
Dow Jones
38,227.99
0.37%
Brent Oil
88.285
0.15%
Bitcoin
63,539.25
-1.47%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Alliance Pharma Plc (APH) Quote

Alliance Pharma Plc

Alliance Pharma Plc (APH)

Australian Primary Hemp Limited
Amphenol Corp
35.00
0.10
(0.29%)
Closed April 26 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
35.00
Bid
34.85
Ask
35.00
Volume
282,174
34.45 Day's Range 35.75
33.70 52 Week Range 72.60
Market Cap
188.242M
Previous Close
34.90
Open
35.75
Last Trade
6
@
35
(AT)
Last Trade Time
Financial Volume
98,062p
VWAP
34.7524
Average Volume (3m)
935,306
Shares Outstanding
540,150,223
Dividend Yield
5.07%
PE Ratio
205.00
Earnings Per Share (EPS)
-
Revenue
167.42M
Net Profit
936k

About Alliance Pharma Plc

Sector
Pharmaceutical Preparations
Industry
Diversified Investment Holding
Website
www.alliancepharmaceuticals.com
Headquarters
Wiltshire, Gbr
Founded
2001
Alliance Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker APH. The last closing price for Alliance Pharma was 34.90p. Over the last year, Alliance Pharma shares have traded in a share price range of 33.70p to 72.60p.

Alliance Pharma currently has 540,150,223 shares outstanding. The market capitalization of Alliance Pharma is £188.24 million. Alliance Pharma has a price to earnings ratio (PE ratio) of 205.00.

APH Latest News

More News

Alliance Pharma PLC Preliminary Results Publication Date

Alliance Pharma PLC 26 April 2024     For immediate release 26 April 2024       ALLIANCE PHARMA ("Alliance", "Company" or the "Group")   Preliminary results publication date   Alliance Pharma...

10 hours ago
RNS Regulatory News

EARNINGS: Lok'n Store has "positive but muted" growth as Shurgard bids

The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by ...

April 22 2024
Alliance News

Alliance Pharma PLC Further update on timing of preliminary results

Alliance Pharma PLC 22 April 2024     For immediate release 22 April 2024     ALLIANCE PHARMA ("Alliance", "Company" or the "Group")   Further update on timing of preliminary results...

April 22 2024
RNS Regulatory News

Alliance Pharma PLC Update on Timing of Preliminary Results

Alliance Pharma PLC 05 April 2024     For immediate release 5 April 2024     ALLIANCE PHARMA ("Alliance", "Company" or the "Group")   Update on timing of preliminary results announcement  ...

April 05 2024
RNS Regulatory News

Alliance Pharma PLC Total Voting Rights

Alliance Pharma PLC 02 April 2024   For immediate release 02 April 2024 ALLIANCE PHARMA PLC ("Alliance" or the "Company")   Total Voting Rights   Alliance Pharma plc (AIM: APH), the...

April 02 2024
RNS Regulatory News

Alliance Pharma PLC Total Voting Rights

Alliance Pharma PLC 04 March 2024   For immediate release 4 March 2024 ALLIANCE PHARMA PLC ("Alliance" or the "Company")   Total Voting Rights   Alliance Pharma plc (AIM: APH), the...

March 04 2024
RNS Regulatory News

Alliance Pharma PLC Notification of Full Year Results

Alliance Pharma PLC 04 March 2024   For immediate release 4 March 2024       ALLIANCE PHARMA PLC ("Alliance", "Company" or "Group")   Notification of Full Year Results, Analyst Meeting and...

March 04 2024
RNS Regulatory News

TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down

The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not sepa ...

February 05 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.4-3.8461538461536.437.1534.25162980935.23758973DE
4-4.4-11.167512690439.439.434.2596168836.38687708DE
12-2.75-7.2847682119237.754634.2593530638.76040709DE
26-3.25-8.4967320261438.254633.7111826938.298253DE
52-27.9-44.356120826762.972.633.7153496846.56678437DE
156-59-62.76595744689412233.7177723166.37425167DE
260-42-54.54545454557712233.7149992769.77811512DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3003
(79.40%)
54.46M
NIVFNewGenIvf Group Ltd
$ 2.0899
(60.76%)
46.93M
RCONRecon Technology Ltd
$ 0.126
(53.66%)
5.58M
FCUVFocus Universal Inc
$ 0.41
(44.83%)
15.57M
PEGYPineapple Energy Inc
$ 0.0735
(41.62%)
250.12M
ISUNiSun Inc
$ 0.1585
(-95.40%)
7.42M
NWGLNature Wood Group Ltd
$ 7.66
(-54.54%)
379.52k
ICLKiClick Interactive Asia Group Ltd
$ 1.35
(-46.64%)
532.41k
NUWENewellis Inc
$ 0.1671
(-42.18%)
13.72M
LGHLWLion Group Holding Ltd
$ 0.0055
(-28.57%)
13.27k
PEGYPineapple Energy Inc
$ 0.0735
(41.62%)
250.12M
SQQQProShares UltraPro Short QQQ
$ 11.44
(-4.67%)
74.4M
INTCIntel Corporation
$ 31.78
(-9.48%)
58.87M
BDRXBiodexa Pharmaceuticals PLC
$ 1.3003
(79.40%)
54.46M
NIVFNewGenIvf Group Ltd
$ 2.0899
(60.76%)
46.93M

Discussion

View Full Feed
justkate justkate 4 minutes ago
HMMMM!! LET'S SEE... ETHEREUM AND THE SEC?? OH WELL I GUESS WELL SEE!! JUST GLAD TO BE ME!! JUST PART OF THE ONE EIGHTY-THREE! TO CHANGE THE EXCHANGE SOUNDS CHALLENGING! JUST WAITING FOR THE DUST TO SETTLE!! PROGRESS CONTINUES! DUST IN THE WIND!! GOLD DUST!! NO WHAT YOU HOLD AND HOLD FOR THE GOLD!!
AABB
sicofbs sicofbs 4 minutes ago
See why I said I am nervous CJ … the inability to complete anything after 5 months is troubling … always a story, a lie, a twist, a oops 🤷‍♂️ they are either totally inept, or just don’t give a 💩
IGPK
getmoreshares getmoreshares 4 minutes ago
At dinner tonight my daughter asked, "Dad, are bugs good to eat?"

I said, "Really, we're not going to talk about this right now."

So, after dinner I said, "Now what did you want to ask me?"

She said, "Oh nothing, there was a bug in your soup, but now it's
Budman33 Budman33 4 minutes ago
Did we die and no notice put out ??
VDRM
Me2Greedy Me2Greedy 4 minutes ago
Timber from here !!
NVDA
georgie18 georgie18 4 minutes ago
INDU...Gap Starting to fill here...Would be great to see the VIX Under 15...🥳
VIX
Vettelover98 Vettelover98 4 minutes ago
And that’s why you’re a paid basher. What do these marketmakers do? they will hire somebody to constantly bash the stock so that they can short it. And why? so they can make money from the share price decreasing and continuing to decrease until they run the company into the ground. And it’s all beca
VPLM
Triple nickle Triple nickle 4 minutes ago
No we’re not
KTRA
Jaxon2010 Jaxon2010 4 minutes ago
Sweet!!
IGPK
dranesthesia1 dranesthesia1 5 minutes ago
Not since .0007 flipper. lol
SPZI
docsetc docsetc 5 minutes ago
Maybe,.... but I would have certainly tied up the IP access. This type of dissolution agreement takes time. CC could have been working all of this up since January, and pressured Harry with it more recently, but that is not probable with all of the SAGA ownership of the IP at the time, that CC sig
ENZC
shurtha2000 shurtha2000 5 minutes ago
Stay out and let it settle
BlazingStocks BlazingStocks 5 minutes ago
$PNPNF - Analyst Coverage Underscores Upside Potential:

The optimistic outlooks and target prices from analysts at Red Cloud Securities(6), Fundamental Research Corp.(7), and Hannam & Partners(8) highlight the significant growth potential for Power Nickel Inc. With targets suggesting
PNPNF
Ironwalker Ironwalker 5 minutes ago
D.A. is a narcissist , 100% driven for self attention, typical of Hollywood actors\ entertainers. D.A. could NOT stand when his chops were getting busted on this site by shareholders, when he using alias. CEO, with all past experience with Canadian stock market knew exactly what he was doing when he
BRAV
Dingbatt Dingbatt 5 minutes ago
while the Ostrich complex has been sitting Idle at the SEC
regarding Naked short selling of everything and anything
Gensler has buried the OTC in an Ant hill in the amazon jungle and keeps pouring honey on the OTC with his moves.
RNVA
LetGoodTimesRoll LetGoodTimesRoll 5 minutes ago
Diggy low, you're watching $RNVA very closely. Have you spent more than you're comfortable losing...? Not that there's anything wrong with that.
RNVA
Nick Papagiorgio Nick Papagiorgio 5 minutes ago
Unfortunately the past is in the past …. With the current dilution there will not be a run like we saw a few years ago, unless major announcements are made public
VPLM
Awl416 Awl416 5 minutes ago
Damn
IFBD
dranesthesia1 dranesthesia1 5 minutes ago
You also call good CEO’s scumbags and lie often to further a personal agenda. So let’s not get too self congratulatory. :)
SPZI
art2426 art2426 5 minutes ago
>>>Amazing that you always bring facts and you’re met with the whiney defenses of negativity.
BIEL
PennyMillions852 PennyMillions852 5 minutes ago
.0004 up!!!
CBIA
bunda bunda 5 minutes ago
chartmaster. check you butt pressure if you cannot wait. piece of shitee
IGPK
koolmc koolmc 5 minutes ago
.0004 up nice .0003 fell quicker than i thought
CBIA
FeMike FeMike 5 minutes ago
I kind of think that NWBO management is holding the door open for us to buy super cheaply and giving us the chance to legally benefit from public information that is effectively as lucrative as if one had inside information given how little understood it is by the market.


Et t
NWBO
stevo321 stevo321 5 minutes ago
What the price target have to do with wamu equity?
COOP

Your Recent History

LSE
APH
Alliance Pharma
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved